Hologic, we strive to save you time at every step along the Breast Health Continuum of Care, ensuring more women have more time in better
health. From routine screening to treatment, our technology improves cancer detection, enhances workflow, reduces facility costs and
ultimately increases patient outcomes.
IMPROVED CANCER DETECTION
accurate and efficient detection is instrumental for better patient outcomes. Hologic's 3D Mammography™ exam can detect up to 65% more invasive breast cancers compared
to conventional 2D mammography, with up to 40% less recalls¹, helping to reduce the physical and emotional burden on
density is known as the highest risk factor for breast cancer² and radiologists are facing a growing need for improved workflow efficiency
as digital breast tomosynthesis (DBT) is expected to become the gold standard for screening in Europe. Quantra™ software provides objective breast density assessment, allowing
clinicians to identify women with dense breasts, facilitating patient management protocols for adjunctive screening.
Hologic, we are dedicated to supporting effective detection, giving you maximum clinical confidence and to deliver the best results for your
patients. Affirm® Prone Breast Biopsy System, the world's first 3D guided biopsy system with the same 3D™ image quality used to located lesions, helps pinpoint subtle lesions
and faint calcifications that might not be visible with older technology - and ultimately may help reduce the number of patients
sent to open surgical biopsy.
UNLOCKING THE ADVANTAGE OF TIME
precious when it comes to effective detection, diagnosis and treatment of breast cancer, which is why we continue to push the frontiers of
science and technology, harnessing new AI and additional imaging capabilities to enable you to achieve earlier and more accurate diagnosis
3DQuorum™ imaging technology powered by Genius AI™ produces 6mm 'SmartSlices' for accurate
diagnosis, accelerating reading and saving time for clinicians while improving data management workflow preventing time delays.
the I-View™ software you can combine the power of Contrast Enhanced Mammography (CEM) with 2D and tomosynthesis images
all in one compression to provide anatomical and functional imaging all in one exam. The use of comprehensive imaging using co-registered
functional and morphological information will accelerate your reading time, lasting about 10 minutes vs. 30-40 minutes for a standard breast
Affirm Contrast Biopsy* targets lesions visible in 2D contrast-enhanced imaging with all images being reviewed
on the AWS in the patient room. As the biopsy takes place in the same room as the diagnostic mammogram, with the addition of the Affirm
Upright breast biopsy guidance system this allows for similar workflow to stereotactic biopsy, but with shorter procedures and lower cost vs
COMPASSIONATE PATIENT CARE
solution, from breast screening to monitoring, is designed with women's comfort and your workflow efficiency in mind, to support you in
delivering excellence in disease management along the entire patient pathway.
Faxitron® Trident® HD Specimen Radiography System, you have no transporting the specimen to another
room for imaging, no waiting for margin confirmation and no costly scheduling delays. Instead, you have the quality images you need to make
informed clinical decisions at the point of care - to help streamline workflow and shorten procedures.
specific imaging modules on SuperSonic® MACH®series like
ShearWave® PLUS elastography, Needle PLUS and TriVu, are designed to improve diagnostic confidence of the
The SmartCurve™ stabilisation system, featuring a curved compression device
mirroring the shape of a woman's breast, was reported by 93% of women to be more comfortable than conventional compression
We are committed to partnering and sharing our expertise to provide you with next generation,
evidence-based solutions to support your patients and clinical practice
across the entire Breast Continuum of Care.
To learn more, explore our scientific webinar series
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium
*Disclaimer:*Affirm Contrast Biopsy solution is not CE marked and not available for
References: 1. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination
with digital mammography. JAMA. 2014 Jun 25; 311(24):2499-507 2. HOLOGIC / CE 44 232 117808 / TUV NORD 0044 / Revision date 08/2021 3. Data On File: DHM-06039 Rev 002 Jennifer Bartoshevich, Teri Orefice, Sajjad Mansoor, et.al Internal Study comparing Hologic's flat paddle to the SmartCurve paddle (18x24cm) (2017).
EMB-01872-EUR-EN Rev 001. ©2022 Hologic, Inc. All rights reserved. Hologic, 3Dimensions, 3DQuorum,
Clarity HD, Genius AI, Intelligent 2D, Quantra, and associated logos are trademarks or registered trademarks of Hologic, Inc. and/or its
subsidiaries in the United States and/or other countries. All other trademarks, registered trademarks and product names are the property of
their respective owners. This information is intended for medical professionals and is not intended as a product solicitation or promotion
where such activities are prohibited. Because Hologic materials are distributed
through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For information on specific products
available for sale in a particular country, please contact your Hologic representative or write to email@example.com
AuntMinnieEurope.com, 671 N Glebe Road, Suite #1610, Arlington, VA 22203 USA